Presentation is loading. Please wait.

Presentation is loading. Please wait.

Avian Influenza A(H5N1) and Risks to Human Health Technical Meeting on Highly Pathogenic Avian Influenza and Human H5N1 infection Rome 27 - 29 June 2007.

Published byCecil Snow Modified over 9 years ago

Similar presentations

Presentation on theme: "Avian Influenza A(H5N1) and Risks to Human Health Technical Meeting on Highly Pathogenic Avian Influenza and Human H5N1 infection Rome 27 - 29 June 2007."— Presentation transcript:

1 Avian Influenza A(H5N1) and Risks to Human Health Technical Meeting on Highly Pathogenic Avian Influenza and Human H5N1 infection Rome 27 - 29 June 2007 Keiji Fukuda Global Influenza Programme World Health Organization

2 Major Public Health Threats of Influenza Seasonal –Greatest health impact over time Avian influenza H5N1 virus –Most often direct/indirect zoonotic infection from infected birds –Infrequently direct contact with an infected person –Other exposures not clearly established Emergence of a human pandemic strain –H5N1 most concern due to spread & pathogenicity –Another novel subtype possible

3 Laboratory-confirmed human H5N1 cases, since 2003 312 cases 190 deaths

4 Hong Kong/156/97 Vietnam/JP14/05 ck/Cambodia/013LC1b/05 Vietnam/1194/04 Vietnam/1203/04 Vietnam/HN30408/05 Thailand/16/04 Vietnam/JPHN30321/05 Clade 1 Hong Kong/213/03 Indonesia/CDC523/06 Indonesia/CDC699/06 Indonesia/CDC326/06 Indonesia/5/05 Indonesia/CDC184/05 Indonesia/7/05 dk/KulonProgoBBVET9/04 ck/Indonesia/CDC25/05 Indonesia/6/05 ck/Brebes/BBVET2/05 Indonesia/CDC594/06* ck/Dairi/BPPVI/05 Clade 2.1 ck/Yunnan/374/04 ck/Yunnan/115/04 ck/Yunnan/493/05 ck/Yunnan/447/05 dk/Guangxi/13/04 ck/Guangxi/12/04 whooping swan/Mongolia/244/05 bar headed gs/Qinghai/1A/05 * Turkey/65596/06 Turkey/15/06 Iraq/207NAMRU3/06 ck/Nigeria/641/06 mld/Italy/332/06 turkey/Turkey/1/05 Egypt/2782NAMRU3/06 Djibouti/5691NAMRU3/06 ck/Nigeria42/06 migratory dk/Jiangxi/2136/05 gs/Kazakhstan/464/05 ck/Krasnodar/01/06 Azerbaijan/011162/06 swan/Iran/754/06 Clade 2.2 dk/Laos3295/06 Anhui/1/05 Anhui/2/05 Japanese white-eye/Hong Kong/1038/06 ck/Malaysia935/06 Vietnam/30850/05 Guangxi/1/05 dk/Hunan/15/04 qa/Guangxi/575/05 dk/Vietnam/Ncvdcdc95/05 Clade 2.3 migratory dk/Jiangxi/1653/05 gs/Guangdong/1/96 * Karo cluster Indonesia/CDC625/06* Phylogenetic tree based on H5 HA Strains in yellow: vaccine strains Vietnam Thailand Cambodia Indonesia Middle east Europe Africa China Laos

5

6 Characteristics of confirmed H5N1 human cases M:F = 0:9 All age groups affected –Higher incidence in age group < 40 years Case fatality ~ 63% Median duration of illness –Onset - hospitalization 4 days –Onset - death 9 days Clinical features –Severe cases feature pneumonia, ARDS –Asymptomatic infection appears rare

7 Risk factors and exposures H5N1 in humans Primary known exposures associated with infected birds –Unprotected handling –Sharing living areas Route of virus entry into humans uncertain Risk appears highest in countries with infected birds where –Human contact with poultry is frequent –Animal disease detection and/or control is a challenge No identifiable exposures for some cases

8 Human-to-Human H5N1 Transmission Epidemiological diagnosis of exclusion –Plausible epidemiological link –No other probable exposures –Viruses consistent –" Limited human-to-human transmission cannot be ruled out" Typically associated with very close prolonged contact between susceptible and severely ill person No occurrence of human-to-human transmission capable of sustained community outbreaks

9 Prevention and treatment of human H5N1 infection One H5N1 vaccine licensed but not yet field tested –Others applications in submission Optimal antiviral treatment regimen is yet unknown –Early oseltamivir treatment might reduce H5N1-associated mortality Antiviral resistance requires monitoring Limited evaluation of other therapies –E.g, immuno-modulators, convalescent sera

10 WHO Strategic Action Plan Pandemic Influenza Strengthen Early Warning system Reduce Human Exposure to H5N1 virus Intensify Rapid Containment operations Build Capacity to cope with pandemic Coordinate Global Scientific Research and Vaccine Development 5 4 3 2 1

11 WHO Global Influenza Surveillance Network

12 Important Current Activities l Implementation of IHR l Continuing development of framework to facilitate sharing of influenza viruses and related benefits l Maintain rapid global threat assessment & response l Clearer operating terms & conditions l Greater access of developing countries to benefits l Short to long term solutions for improving pandemic & H5 vaccine situation l Stockpiles l Global Pandemic Influenza Vaccine Action Plan

13 H5N1 Cluster Graph Cluster –Two or more epidemiologically linked cases –At least one has a lab-confirmed H5N1 infection –Inclusion of fatal probable cases Unexplained deaths linked epidemiologically to a confirmed case (probable case) Cases in clusters

Download ppt "Avian Influenza A(H5N1) and Risks to Human Health Technical Meeting on Highly Pathogenic Avian Influenza and Human H5N1 infection Rome 27 - 29 June 2007."

Similar presentations

Dr S Aboobakar Regional Public Health Superintendent.

Dr S Aboobakar Regional Public Health Superintendent.
Regional Health Focus Rome | 27 – 29 June 2007 1 |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.

Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”

U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
Communicable Disease Surveillance & Response WHO-WPRO Pandemic (H1N1) 2009 situation and response in the Western Pacific Region Takeshi Kasai Communicable.

Communicable Disease Surveillance & Response WHO-WPRO Pandemic (H1N1) 2009 situation and response in the Western Pacific Region Takeshi Kasai Communicable.
FDA H5N1 Update: Classification of H5N1 Viruses and Development of Vaccine Reference Strains FDA H5N1 Update: Classification of H5N1 Viruses and Development.

FDA H5N1 Update: Classification of H5N1 Viruses and Development of Vaccine Reference Strains FDA H5N1 Update: Classification of H5N1 Viruses and Development.
Avian Influenza – The Bird Flu

Avian Influenza – The Bird Flu
Avian Influenza / Pandemic Influenza Neyla Gargouri Darwaza, M.D. Surveillance Department Directorate of Disease Control Ministry of Health, Jordan.

Avian Influenza / Pandemic Influenza Neyla Gargouri Darwaza, M.D. Surveillance Department Directorate of Disease Control Ministry of Health, Jordan.
So Far Primarily an Avian Disease Considering geographic spread and lethality in birds – very little human disease Fear that the virus may develop the.

So Far Primarily an Avian Disease Considering geographic spread and lethality in birds – very little human disease Fear that the virus may develop the.
Avian influenza A simple introduction.

Avian influenza A simple introduction.
Mmmmm Mohamed M. B. Alnoor CHP400 COMMUNITY HEALTH PROGRAM-II Avian Influenza H5N1 Epidemiology & Control mmmmm.

Mmmmm Mohamed M. B. Alnoor CHP400 COMMUNITY HEALTH PROGRAM-II Avian Influenza H5N1 Epidemiology & Control mmmmm.
Bird Flu.  Bird flu, also known as Avian Influenza, is a type A influenza virus. It is fatal to humans. Bird flu spreads between both wild and pet birds.

Bird Flu.  Bird flu, also known as Avian Influenza, is a type A influenza virus. It is fatal to humans. Bird flu spreads between both wild and pet birds.
Andrew Pelletier, MD, MPH Maine Department of Health and Human Services June 26, 2006 Pandemic Influenza.

Andrew Pelletier, MD, MPH Maine Department of Health and Human Services June 26, 2006 Pandemic Influenza.
Nicole J. Cohen, MD, MSc Chicago Department of Public Health

Nicole J. Cohen, MD, MSc Chicago Department of Public Health
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus

Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.

SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
By Andrew Garaniel University of California, Irvine

By Andrew Garaniel University of California, Irvine
ONE WORLD. ONE HEALTH Rockefeller University New York – 29 September 2004 History of zoonotic avian influenza By F.X. Meslin Co-ordinator, Strategy development.

ONE WORLD. ONE HEALTH Rockefeller University New York – 29 September 2004 "History of zoonotic avian influenza" By F.X. Meslin Co-ordinator, Strategy development.
Preparing for an Influenza Pandemic in Westminster Health and Community Services Overview and Scrutiny Committee 9 Oct 2006 Dr Margaret Guy Director of.

Preparing for an Influenza Pandemic in Westminster Health and Community Services Overview and Scrutiny Committee 9 Oct 2006 Dr Margaret Guy Director of.
DR. JULIE LOUISE GERBERDING DIRECTOR CENTERS FOR DISEASE CONTROL AND PREVENTION CURRENT STATUS OF AVIAN INFLUENZA AND PANDEMIC THREAT PRESENTATION TO IOM,

DR. JULIE LOUISE GERBERDING DIRECTOR CENTERS FOR DISEASE CONTROL AND PREVENTION CURRENT STATUS OF AVIAN INFLUENZA AND PANDEMIC THREAT PRESENTATION TO IOM,
Technical support provided by: Highly Pathogenic Avian Influenza Control Programme Threats and Problems of Bird Flu Market chain cleaning and disinfection.

Technical support provided by: Highly Pathogenic Avian Influenza Control Programme Threats and Problems of Bird Flu Market chain cleaning and disinfection.

Similar presentations

Ads by Google